Ranibizumab - PDFSEARCH.IO - Document Search Engine

Ranibizumab
Results: 261

#	Item
31	Supplement to March 2015 Guidance for the Clinical Management Add to Reading List Source URL: retinatoday.com Language: English - Date: 2015-03-10 15:04:10 Choroidal neovascularization Bevacizumab Myopia Vascular endothelial growth factor Macular degeneration Ranibizumab Retinal detachment Maculopathy Retina Medicine Ophthalmology Health
32	VI Supplement to MarchEW Add to Reading List Source URL: www.retinatoday.com Language: English - Date: 2015-03-10 15:04:01 Angiology Vascular endothelial growth factor Ranibizumab Diabetic retinopathy Bevacizumab Macular edema Macular degeneration Laser coagulation Retina Medicine Ophthalmology Vision
33	An upper limit for macromolecular crowding effects Add to Reading List Source URL: www.cellandbioscience.com Language: English Ophthalmology Vascular endothelial growth factor Diabetic retinopathy Blood–retinal barrier Pericyte PEDF Ranibizumab Retina Choroidal neovascularization Medicine Biology Angiology
34	A Avastin versus Lucentis: Why It Matters lthough Lucentis is a remarkably safe and effective treatment for exudative macular degeneration, it could cost our health care system over $9 billion, which Add to Reading List Source URL: mrmcmed.org Language: English - Date: 2007-01-08 17:20:10 Bevacizumab Macular degeneration Ophthalmology Genentech Ranibizumab Choroidal neovascularization Vascular endothelial growth factor Presumed ocular histoplasmosis syndrome Off-label use Medicine Health Pharmacology
35	Habibi et al. Biomarker Research 2014, 2:15 http://www.biomarkerres.org/contentRESEARCH Open Access Add to Reading List Source URL: www.biomarkerres.org Language: English Growth factors Vascular endothelial growth factor Choroidal neovascularization Ranibizumab Bevacizumab Macular degeneration Angiogenesis inhibitor Angiogenesis Maculopathy Medicine Angiology Health
36	English Special # 6 o 5 I F 4 X F E J T I $ P V O D J M P O 5F D I O P M P H Z " T T F T T N F O U J O ) F B M U I $ B S F . & % * $"4 $& / $ & 1 3"$5 $ & S P E C I A L J O I N T N E W S L E T T E R F RO M S Add to Reading List Source URL: www.sbu.se Language: English - Date: 2008-07-04 05:26:54 Ranibizumab Vascular endothelial growth factor HPV vaccine Macular degeneration Dementia Human papillomavirus AIDS Medicine Health Papillomavirus
37	RANZCO 2014 46th Annual Scientific Congress – POSTERS PROGRAM POSTER 1 PRESENTER Dr Warren Apel Add to Reading List Source URL: ranzco2014.com.au Language: English - Date: 2014-11-18 22:46:56 Blindness Glaucoma Cataract surgery Vascular endothelial growth factor Macular degeneration Ranibizumab Bevacizumab Cataract Macular edema Medicine Ophthalmology Health
38	6.2 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea®; Bayer Australia Ltd. Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Vascular endothelial growth factor Bevacizumab Macular degeneration Macular edema Diabetic retinopathy Laser coagulation Retina Low vision Medicine Ophthalmology Vision
39	Public Summary Document – November 2014 PBAC Meeting 7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Vascular endothelial growth factor Bevacizumab Macular edema Central retinal vein occlusion Macular degeneration Diabetic retinopathy Macula of retina Central retinal vein Ophthalmology Medicine Health
40	7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea®; Bayer Australia Ltd. Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Ranibizumab Bevacizumab Vascular endothelial growth factor Macular degeneration Macular edema Pharmaceutical Benefits Scheme Central retinal vein occlusion Off-label use Macula of retina Medicine Ophthalmology Health